Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: exploratory analysis, based on the results of post-marketing surveillance, according to prior chemotherapy status and in patients without concomitant use of second-generation androgen-receptor axis-targeted agents

BACKGROUND: Based on results from Japanese post-marketing surveillance, exploratory analyses were performed to investigate real-world outcomes of radium-223 for metastatic CRPC (mCRPC) according to patient characteristics. METHODS: This non-interventional, prospective study enrolled mCRPC patients s...

Descripción completa

Detalles Bibliográficos
Autores principales: Uemura, Hirotsugu, Masumori, Naoya, Takahashi, Shunji, Hosono, Makoto, Kinuya, Seigo, Sunaya, Toshiyuki, Horio, Tomoyo, Okayama, Yutaka, Kakehi, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979648/
https://www.ncbi.nlm.nih.gov/pubmed/33575828
http://dx.doi.org/10.1007/s10147-020-01850-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979648/
https://www.ncbi.nlm.nih.gov/pubmed/33575828
http://dx.doi.org/10.1007/s10147-020-01850-3

Ejemplares similares